PRODUCT DETAILS

Product Image

LUGONIST DEPOT 3.75MG | Leuprolide Acetate Depot Injection.

$

LUGONIST DEPOT 3.75MG contains Leuprolide Acetate 3.75mg, a prescription GnRH agonist that provides sustained suppression of sex hormones for specialist-managed hormone-dependent conditions.

Unit:
  • N/A
Total: $

 

LUGONIST DEPOT 3.75MG | Leuprolide Acetate Depot Injection

 

LUGONIST DEPOT 3.75MG contains Leuprolide Acetate 3.75mg, a prescription GnRH agonist that provides sustained suppression of sex hormones for specialist-managed hormone-dependent conditions.

LUGONIST DEPOT 3.75MG

LUGONIST DEPOT 3.75MG (Leuprolide Acetate 3.75mg): Comprehensive Guide

Product Summary

LUGONIST DEPOT 3.75MG contains Leuprolide Acetate 3.75mg and belongs to the pharmaceutical class Gonadotropin-Releasing Hormone (GnRH) Agonists. It is a long-acting depot hormonal medicine used under specialist medical supervision.

Leuprolide is a synthetic analogue of naturally occurring GnRH. When administered continuously rather than in the body's normal pulsatile pattern, it ultimately suppresses pituitary secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). This reduces the production of sex hormones such as testosterone and estrogen.

Leuprolide depot formulations are used in specialist treatment protocols for various hormone-dependent conditions, with the specific approved indications depending on the formulation, patient population, and local regulatory labeling.

Product Full Description

LUGONIST DEPOT 3.75MG contains Leuprolide Acetate 3.75mg in a depot formulation designed to provide sustained hormonal activity. Following administration, leuprolide initially stimulates GnRH receptors in the pituitary gland. Continued exposure causes receptor desensitization and suppression of LH and FSH secretion. The resulting reduction in gonadal hormone production provides the therapeutic basis for its use in selected oncology, gynecological, and reproductive treatment protocols. Because hormonal suppression can have significant clinical effects, treatment should be prescribed and monitored by an appropriately qualified healthcare professional.

Drug Class

Active Ingredient: Leuprolide Acetate

Strength: 3.75mg

Drug Class: Gonadotropin-Releasing Hormone (GnRH) Agonist

Therapeutic Category: Hormonal / Endocrine Medicine

Dosage Form: Depot Injection

Prescription Status: Prescription-only medicine

Key Benefits of LUGONIST DEPOT 3.75MG

Provides sustained suppression of gonadal hormone production.

Reduces testosterone production when used in appropriate androgen-dependent conditions.

Reduces estrogen production when used in appropriate estrogen-dependent conditions.

Provides prolonged hormonal activity through a depot formulation.

Can support specialist treatment protocols requiring controlled hormonal suppression.

How LUGONIST DEPOT 3.75MG Works

Leuprolide acts as a GnRH receptor agonist.

Initially, it stimulates the pituitary gland and may temporarily increase LH and FSH secretion. With continuous exposure, the pituitary GnRH receptors become desensitized. LH and FSH production subsequently decreases, leading to suppression of testosterone production in men and estrogen production in women.

This mechanism allows sustained reduction of sex-hormone levels when leuprolide is administered according to an appropriate treatment schedule.

Usage Instructions

Use LUGONIST DEPOT 3.75MG only as prescribed by your healthcare professional.

The depot injection should be prepared and administered according to the product's approved instructions.

Do not self-administer unless specifically trained and instructed by your healthcare provider.

Follow the exact injection schedule recommended by your specialist.

Do not increase, decrease, or discontinue treatment without medical advice.

Attend scheduled laboratory tests and clinical follow-ups as recommended.

The exact administration technique and treatment interval should follow the manufacturer's instructions for the specific LUGONIST DEPOT presentation.

Medicinal Advantages

Produces sustained suppression of reproductive hormone production.

Provides long-acting hormonal therapy in a depot formulation.

Supports controlled reduction of testosterone or estrogen levels when medically indicated.

Can be incorporated into specialist treatment protocols for hormone-dependent conditions.

Offers prolonged therapeutic activity compared with short-acting GnRH administration.

IMPORTANT: LUGONIST DEPOT 3.75MG is a prescription-only hormonal medicine. It should be used only after appropriate medical evaluation and under the supervision of a qualified healthcare professional.

Off-Label Uses

Leuprolide may be prescribed off-label in selected reproductive, gynecological, endocrinological, or oncology settings when supported by specialist judgment and applicable clinical evidence.

Any off-label use should be undertaken only under specialist medical supervision.

Expert Advice for Optimal Use

Maintain the prescribed injection schedule.

Attend regular follow-up appointments during treatment.

Your healthcare provider may monitor hormone levels and other disease-specific laboratory parameters.

Discuss any existing bone-health concerns with your doctor before prolonged treatment.

Inform your healthcare professional about all medicines and supplements you use.

Do not discontinue long-term therapy without medical advice.

Precautions

Prescription Medicine

LUGONIST DEPOT 3.75MG should be used only under qualified medical supervision.

Pregnancy

Leuprolide is generally not intended for use during pregnancy. Appropriate pregnancy assessment should be performed when clinically required before treatment.

Bone Health

Prolonged suppression of estrogen or testosterone can affect bone mineral density. Patients receiving extended therapy may require assessment of bone health.

Initial Hormonal Flare

Leuprolide may initially cause a temporary increase in sex-hormone levels before sustained suppression occurs. The clinical importance of this effect depends on the condition being treated.

Medical Monitoring

Regular clinical monitoring helps assess treatment response and determine the appropriate duration of therapy.

Storage Instructions

Store according to the manufacturer's recommended storage conditions.

Protect the depot formulation from excessive heat and direct sunlight.

Keep the product in its original packaging until preparation.

Do not use if the package is damaged or the product is compromised.

Keep out of reach of children.

Frequently Asked Questions (FAQs)

What is LUGONIST DEPOT 3.75MG?

LUGONIST DEPOT 3.75MG is a depot hormonal injection containing Leuprolide Acetate 3.75mg, a GnRH agonist used to produce sustained suppression of sex-hormone production.

What is the active ingredient in LUGONIST DEPOT 3.75MG?

It contains Leuprolide Acetate 3.75mg.

What type of medicine is LUGONIST DEPOT 3.75MG?

It is a Gonadotropin-Releasing Hormone (GnRH) Agonist belonging to the hormonal/endocrine medicine class.

How does Leuprolide Acetate work?

Continuous leuprolide exposure suppresses pituitary LH and FSH secretion after an initial stimulation phase, ultimately reducing the body's production of sex hormones.

Is LUGONIST DEPOT 3.75MG a prescription medicine?

Yes. LUGONIST DEPOT 3.75MG is a prescription-only hormonal medicine and should be used under qualified medical supervision.

Does Leuprolide immediately suppress hormones?

No. Leuprolide can initially produce a temporary hormonal increase before continued treatment results in sustained suppression.

Product Tags

LUGONIST DEPOT 3.75MG, Leuprolide Acetate 3.75mg, Leuprolide Depot Injection, GnRH Agonist, GnRH Analogue, Leuprolide injection, depot hormonal injection, hormonal therapy, endocrine medicine, prescription hormone injection.

Jonathan Andrew

Happy Customer

Review

Post Your Review